Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$400.16 USD
-1.98 (-0.49%)
Updated May 2, 2024 04:00 PM ET
After-Market: $398.01 -2.15 (-0.54%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Price, Consensus and EPS Surprise
VRTX 400.16 -1.98(-0.49%)
Will VRTX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for VRTX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VRTX
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know
Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know
VRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Unveiling Vertex (VRTX) Q1 Outlook: Wall Street Estimates for Key Metrics
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
Vertex (VRTX) to Report Q1 Earnings: What's in the Cards?
Other News for VRTX
Global company events calendar
Invest In A Revolutionary Gene Therapy With CRISPR Therapeutics
Vortex Energy Spearheads Innovative Hydrogen Storage Trial
Global company events calendar
Analysts Offer Insights on Healthcare Companies: Accolade (ACCD), Vertex Pharmaceuticals (VRTX) and Zimmer Biomet Holdings (ZBH)